scholarly journals The effect of exergaming on executive functions in children with ADHD: A randomized clinical trial

2019 ◽  
Vol 29 (8) ◽  
pp. 1243-1253 ◽  
Author(s):  
Valentin Benzing ◽  
Mirko Schmidt
Keyword(s):  
Clinical Trial ◽  
Executive Functions ◽  
Randomized Clinical Trial ◽  
Children With Adhd

scholarly journals Comparing treatments for children with ADHD and word reading difficulties: A randomized clinical trial.

2017 ◽  
Vol 85 (5) ◽  
pp. 434-446 ◽  
Author(s):  
Leanne Tamm ◽  
Carolyn A. Denton ◽  
Jeffery N. Epstein ◽  
Christopher Schatschneider ◽  
Heather Taylor ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Word Reading ◽  
Reading Difficulties ◽  
Children With Adhd

Attachment Competences in Children With ADHD During the Social-Skills Training and Attachment (SOSTRA) Randomized Clinical Trial

2014 ◽  
Vol 19 (10) ◽  
pp. 865-871 ◽  
Author(s):  
Ole Jakob Storebø ◽  
Maria Skoog ◽  
Pernille Darling Rasmussen ◽  
Per Winkel ◽  
Christian Gluud ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Social Skills ◽  
Randomized Clinical Trial ◽  
Social Skills Training ◽  
Skills Training ◽  
Children With Adhd ◽  
The Social

scholarly journals A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder

2013 ◽  
Vol 16 (9) ◽  
pp. 1959-1973 ◽  
Author(s):  
Hsing-Chang Ni ◽  
Chi-Yung Shang ◽  
Susan Shur-Fen Gau ◽  
Yu-Ju Lin ◽  
Hui-Chun Huang ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Attention Deficit Hyperactivity Disorder ◽  
Working Memory ◽  
Executive Functions ◽  
Randomized Clinical Trial ◽  
Attention Deficit ◽  
Spatial Planning ◽  
Spatial Working Memory ◽  
Psychiatric Interview ◽  
Hyperactivity Disorder

Abstract Results regarding the effects of methylphenidate and atomoxetine on executive functions were inconsistent and no study has directly compared the efficacy of these two medications in improving executive functions in adults with attention-deficit hyperactivity disorder (ADHD). We conducted an 8–10 wk, open-label, head-to-head, randomized clinical trial involving adults with a clinical diagnosis of ADHD confirmed by psychiatric interview. The two treatment arms were immediate-release methylphenidate (IR-methylphenidate) (n = 31) and atomoxetine once daily (n = 32). Executive functions were assessed by the Cambridge Neuropsychological Test Automated Battery (CANTAB), including spatial working memory, spatial span, intra-extra dimensional set shifts, rapid visual information processing and Stockings of Cambridge (SOC). In addition to the symptom assessments at baseline (week 0), visit 2 (week 4–5) and visit 3 (week 8–10), they received CANTAB assessments at baseline and visit 3 (60.4 ± 6.3 d). Compared to baseline, adults treated with atomoxetine showed significant improvement in spatial working memory, spatial short-term memory, sustained attention and spatial planning at visit 3; adults treated with IR-methylphenidate showed significant improvement in spatial working memory at visit 3. Comparing the magnitude of improvement in executive functions between these two medications, the effect was generally similar for the two groups, although atomoxetine might have significantly greater efficacy than IR-methylphenidate in terms of improving spatial planning (SOC). Our results provide evidence to support that both IR-methylphenidate and atomoxetine improved various executive functions in adults with ADHD with greater improvement in atomoxetine than IR-methylphenidate in spatial planning.

scholarly journals A family–school intervention for children with ADHD: Results of a randomized clinical trial.

2012 ◽  
Vol 80 (4) ◽  
pp. 611-623 ◽  
Author(s):  
Thomas J. Power ◽  
Jennifer A. Mautone ◽  
Stephen L. Soffer ◽  
Angela T. Clarke ◽  
Stephen A. Marshall ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
School Intervention ◽  
Children With Adhd

scholarly journals Improving homework performance among children with ADHD: A randomized clinical trial.

2017 ◽  
Vol 85 (2) ◽  
pp. 111-122 ◽  
Author(s):  
Brittany M. Merrill ◽  
Anne S. Morrow ◽  
Amy R. Altszuler ◽  
Fiona L. Macphee ◽  
Elizabeth M. Gnagy ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Children With Adhd

Virtual Remediation Versus Methylphenidate to Improve Distractibility in Children With ADHD: A Controlled Randomized Clinical Trial Study

2018 ◽  
Vol 24 (2) ◽  
pp. 326-335 ◽  
Author(s):  
Stéphanie Bioulac ◽  
Jean-Arthur Micoulaud-Franchi ◽  
Jenna Maire ◽  
Manuel P. Bouvard ◽  
Albert A. Rizzo ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Performance Test ◽  
Rating Scale ◽  
Cognitive Remediation ◽  
Continuous Performance Test ◽  
Virtual Classroom ◽  
Children With Adhd ◽  
Before And After ◽  
Therapeutic Tools

Objective: Virtual environments have been used to assess children with ADHD but have never been tested as therapeutic tools. We tested a new virtual classroom cognitive remediation program to improve symptoms in children with ADHD. Method: In this randomized clinical trial, 51 children with ADHD (7-11 years) were assigned to a virtual cognitive remediation group, a methylphenidate group, or a psychotherapy group. All children were evaluated before and after therapy with an ADHD Rating Scale, a Continuous Performance Test (CPT), and a virtual classroom task. Results: After therapy by virtual remediation, children exhibited significantly higher numbers of correct hits on the virtual classroom and CPT. These improvements were equivalent to those observed with methylphenidate treatment. Conclusion: Our study demonstrates for the first time that a cognitive remediation program delivered in a virtual classroom reduces distractibility in children with ADHD and could replace methylphenidate treatment in specific cases.

Sign in / Sign up

Export Citation Format

Share Document